155 related articles for article (PubMed ID: 36544700)
1. Evaluation of the role of local therapy in patients with cN1M0 prostate cancer: A population-based study from the SEER database.
Qi F; Xu W; Li L; Li X; Xu Z
Front Oncol; 2022; 12():1050317. PubMed ID: 36544700
[TBL] [Abstract][Full Text] [Related]
2. Effect on survival of local treatment in patients with low prostate-specific antigen, high Gleason score prostate cancer: a population-based propensity score-matched analysis.
Liu S; Wang XY; Huang TB; Niu Q; Yao K; Song X; Zhou SY; Chen Z; Zhou GC
Ann Palliat Med; 2020 Jul; 9(4):1708-1717. PubMed ID: 32527134
[TBL] [Abstract][Full Text] [Related]
3. Survival outcomes of patients treated with local therapy for nonmetastatic prostate cancer with high prostate-specific antigen concentrations.
Ślusarczyk A; Baboudjian M; Zapała P; Yanagisawa T; Miszczyk M; Chlosta M; Krumpoeck P; Moschini M; Gandaglia G; Ploussard G; Rivas JG; Życzkowski M; Karakiewicz PI; Radziszewski P; Leapman MS; Shariat SF; Rajwa P
Prostate; 2023 Nov; 83(15):1504-1515. PubMed ID: 37545342
[TBL] [Abstract][Full Text] [Related]
4. Survival outcomes of radical prostatectomy and external beam radiotherapy in clinically localized high-risk prostate cancer: a population-based, propensity score matched study.
Gu X; Gao X; Cui M; Xie M; Ma M; Qin S; Li X; Qi X; Bai Y; Wang D
Cancer Manag Res; 2018; 10():1061-1067. PubMed ID: 29773955
[TBL] [Abstract][Full Text] [Related]
5. Overall survival and cancer-specific survival were improved in local treatment of metastatic prostate cancer.
Miao Q; Wei Z; Liu C; Ye Y; Cheng G; Song Z; Chen K; Zhang Y; Chen J; Yue C; Ruan H; Zhang X
Front Oncol; 2023; 13():1130680. PubMed ID: 37207146
[TBL] [Abstract][Full Text] [Related]
6. Local treatment Associated With Prognosis among Men With Metastatic Prostate Cancer: A SEER-Based Study.
Zhou J; Cao Y; Chen H; Wu Y; Ding J; Qi J
Clin Genitourin Cancer; 2023 Jun; 21(3):e204-e215. PubMed ID: 36858922
[TBL] [Abstract][Full Text] [Related]
7. Mucinous Prostate Cancer Shows Similar Prognosis to Typical Prostate Acinar Carcinoma: A Large Population-Based and Propensity Score-Matched Study.
Zhao F; Yu X; Xu M; Ye S; Zang S; Zhong W; Ren G; Chen X; Yan S
Front Oncol; 2019; 9():1467. PubMed ID: 31998638
[No Abstract] [Full Text] [Related]
8. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
[TBL] [Abstract][Full Text] [Related]
9. Local Therapy Improves Survival in Metastatic Prostate Cancer.
Leyh-Bannurah SR; Gazdovich S; Budäus L; Zaffuto E; Briganti A; Abdollah F; Montorsi F; Schiffmann J; Menon M; Shariat SF; Fisch M; Chun F; Steuber T; Huland H; Graefen M; Karakiewicz PI
Eur Urol; 2017 Jul; 72(1):118-124. PubMed ID: 28385454
[TBL] [Abstract][Full Text] [Related]
10. Survival Outcomes of Radical Prostatectomy + Extended Pelvic Lymph Node Dissection and Radiotherapy in Prostate Cancer Patients With a Risk of Lymph Node Invasion Over 5%: A Population-Based Analysis.
Chen J; Ni Y; Sun G; Zhu S; Zhao J; Wang Z; Zhang H; Zhu X; Zhang X; Dai J; Shen P; Zeng H
Front Oncol; 2020; 10():607576. PubMed ID: 33324569
[TBL] [Abstract][Full Text] [Related]
11. Pelvic lymph node dissection and its extent on survival benefit in prostate cancer patients with a risk of lymph node invasion >5%: a propensity score matching analysis from SEER database.
Chen J; Wang Z; Zhao J; Zhu S; Sun G; Liu J; Zhang H; Zhang X; Shen P; Shi M; Zeng H
Sci Rep; 2019 Nov; 9(1):17985. PubMed ID: 31784574
[TBL] [Abstract][Full Text] [Related]
12. Survival Outcomes for Metastatic Prostate Cancer Patients Treated With Radical Prostatectomy or Radiation Therapy: A SEER-based Study.
Jin K; Qiu S; Jin H; Zheng X; Zhou X; Jin D; Li J; Yang L; Wei Q
Clin Genitourin Cancer; 2020 Dec; 18(6):e705-e722. PubMed ID: 32763123
[TBL] [Abstract][Full Text] [Related]
13. Identifying the Candidates Who Will Benefit From Extended Pelvic Lymph Node Dissection at Radical Prostatectomy Among Patients With Prostate Cancer.
Yang G; Xie J; Guo Y; Yuan J; Wang R; Guo C; Peng B; Yao X; Yang B
Front Oncol; 2021; 11():790183. PubMed ID: 35155191
[TBL] [Abstract][Full Text] [Related]
14. Effects of surgery on survival of elderly patients with gallbladder cancer: A propensity score matching analysis of the SEER database.
Xu X; Wang J; Duan Q
Front Oncol; 2023; 13():1083618. PubMed ID: 36937413
[TBL] [Abstract][Full Text] [Related]
15. Persistent Prostate-Specific Antigen After Radical Prostatectomy and Its Impact on Oncologic Outcomes.
Preisser F; Chun FKH; Pompe RS; Heinze A; Salomon G; Graefen M; Huland H; Tilki D
Eur Urol; 2019 Jul; 76(1):106-114. PubMed ID: 30772034
[TBL] [Abstract][Full Text] [Related]
16. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.
Lughezzani G; Gallina A; Larcher A; Briganti A; Capitanio U; Suardi N; Lista G; Abrate A; Sangalli MN; Buffi N; Cestari A; Guazzoni G; Rigatti P; Montorsi F
BJU Int; 2013 May; 111(5):723-30. PubMed ID: 22487441
[TBL] [Abstract][Full Text] [Related]
17. Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study.
Culp SH; Schellhammer PF; Williams MB
Eur Urol; 2014 Jun; 65(6):1058-66. PubMed ID: 24290503
[TBL] [Abstract][Full Text] [Related]
18. Elderly patients aged ≥ 75 years with locally advanced prostate cancer may benefit from local treatment: a population-based propensity score-adjusted analysis.
Sheng W; Kirschner-Hermanns R; Zhang H
World J Urol; 2019 Feb; 37(2):317-325. PubMed ID: 29951790
[TBL] [Abstract][Full Text] [Related]
19. Survival outcomes of locally advanced prostate cancer in patients aged < 50 years after local therapy in the contemporary US population.
Sheng W; Zhang H; Lu Y
Int Urol Nephrol; 2018 Aug; 50(8):1435-1444. PubMed ID: 29982959
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy benefited the survival of patients with intestinal-type gastric adenocarcinoma: a SEER population-based study.
Chu Y; Xu B; Song Q; Hu Q
Clin Transl Oncol; 2021 Jan; 23(1):164-171. PubMed ID: 32488805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
